Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis.

Henry D, Lim LL, Garcia Rodriguez LA, Perez Gutthann S, Carson JL, Griffin M, Savage R, Logan R, Moride Y, Hawkey C, Hill S, Fries JT.

BMJ. 1996 Jun 22;312(7046):1563-6.

PMID:
8664664
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Variability in risk of gastrointestinal complications with different nonsteroidal anti-inflammatory drugs.

García Rodríguez LA.

Am J Med. 1998 Mar 30;104(3A):30S-34S; discussion 41S-42S.

PMID:
9572318
[PubMed - indexed for MEDLINE]
3.

Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

García Rodríguez LA, Jick H.

Lancet. 1994 Mar 26;343(8900):769-72. Erratum in: Lancet 1994 Apr 23;343(8904):1048.

PMID:
7907735
[PubMed - indexed for MEDLINE]
4.
5.

Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project).

Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F, Sturkenboom M, Perez-Gutthann S; Safety of Non-Steroidal Anti-Inflammatory Drugs (SOS) Project.

Drug Saf. 2012 Dec 1;35(12):1127-46. doi: 10.2165/11633470-000000000-00000. Review.

PMID:
23137151
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Nonsteroidal antiinflammatory drugs, ulcers and risk: a collaborative meta-analysis.

García Rodríguez LA.

Semin Arthritis Rheum. 1997 Jun;26(6 Suppl 1):16-20.

PMID:
9219315
[PubMed - indexed for MEDLINE]
7.

Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies.

McGettigan P, Henry D.

PLoS Med. 2011 Sep;8(9):e1001098. doi: 10.1371/journal.pmed.1001098. Epub 2011 Sep 27. Review.

PMID:
21980265
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Gastrointestinal tract bleeding associated with naproxen sodium vs ibuprofen.

Strom BL, Schinnar R, Bilker WB, Feldman H, Farrar JT, Carson JL.

Arch Intern Med. 1997 Dec 8-22;157(22):2626-31.

PMID:
9531232
[PubMed - indexed for MEDLINE]
9.

Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction.

Hernández-Díaz S, Varas-Lorenzo C, García Rodríguez LA.

Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):266-74.

PMID:
16611201
[PubMed - indexed for MEDLINE]
10.

Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding.

Massó González EL, Patrignani P, Tacconelli S, García Rodríguez LA.

Arthritis Rheum. 2010 Jun;62(6):1592-601. doi: 10.1002/art.27412.

PMID:
20178131
[PubMed - indexed for MEDLINE]
Free Article
11.

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs.

Langman MJ, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RF, Murphy M, Vessey MP, Colin-Jones DG.

Lancet. 1994 Apr 30;343(8905):1075-8. Erratum in: Lancet 1994 May 21;343(8908):1302.

PMID:
7909103
[PubMed - indexed for MEDLINE]
12.

Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.

Russell RI.

Ital J Gastroenterol Hepatol. 1999;31 Suppl 1:S14-8. Review.

PMID:
10379464
[PubMed - indexed for MEDLINE]
13.

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial.

Schnitzer TJ, Burmester GR, Mysler E, Hochberg MC, Doherty M, Ehrsam E, Gitton X, Krammer G, Mellein B, Matchaba P, Gimona A, Hawkey CJ; TARGET Study Group.

Lancet. 2004 Aug 21-27;364(9435):665-74.

PMID:
15325831
[PubMed - indexed for MEDLINE]
14.

Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.

Biskupiak JE, Brixner DI, Howard K, Oderda GM.

J Pain Palliat Care Pharmacother. 2006;20(3):7-14.

PMID:
16931473
[PubMed - indexed for MEDLINE]
15.

Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s.

Hernández-Díaz S, Rodríguez LA.

Arch Intern Med. 2000 Jul 24;160(14):2093-9. Review.

PMID:
10904451
[PubMed - indexed for MEDLINE]
16.

Low-dose diclofenac, naproxen, and ibuprofen cohort study.

Pérez-Gutthann S, García-Rodríguez LA, Duque-Oliart A, Varas-Lorenzo C.

Pharmacotherapy. 1999 Jul;19(7):854-9.

PMID:
10417034
[PubMed - indexed for MEDLINE]
17.

The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.

Hunt RH, Harper S, Watson DJ, Yu C, Quan H, Lee M, Evans JK, Oxenius B.

Am J Gastroenterol. 2003 Aug;98(8):1725-33.

PMID:
12907325
[PubMed - indexed for MEDLINE]
18.

Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding.

Kaufman DW, Kelly JP, Sheehan JE, Laszlo A, Wiholm BE, Alfredsson L, Koff RS, Shapiro S.

Clin Pharmacol Ther. 1993 Apr;53(4):485-94.

PMID:
8477566
[PubMed - indexed for MEDLINE]
19.

Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data.

Lewis SC, Langman MJ, Laporte JR, Matthews JN, Rawlins MD, Wiholm BE.

Br J Clin Pharmacol. 2002 Sep;54(3):320-6.

PMID:
12236853
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk